March 17, 2020 / 10:53 AM / 16 days ago

BRIEF-Mallinckrodt Completes Rolling Submission Of New Drug Application To The FDA For Terlipressin

March 17 (Reuters) - Mallinckrodt Plc:

* MALLINCKRODT COMPLETES ROLLING SUBMISSION OF NEW DRUG APPLICATION TO THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) FOR TERLIPRESSIN FOR THE TREATMENT OF PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 (HRS-1) Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below